Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Clinical Outcomes of Cancer-Associated Thrombosis Beyond 6 Months of Anticoagulation

Shyam K Poudel, Chandana A Reddy, MS, Deborah Y Park, BS, Mailey L Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS, Jung-Min Song, RN,CNS, Keith R McCrae, MD, Alok A Khorana, MD, Dana E Angelini, MD

Blood (2019) 134 (Supplement_1): 3458.

https://doi.org/10.1182/blood-2019-127581

Published: 2019

Journal Articles

Recurrent Intracranial Hemorrhage and Venous Thromboembolism Following Initial Intracranial Hemorrhage in Patients with Brain Tumors on Anticoagulation

Brian J. Carney, MD, Erik J. Uhlmann, MD, Maneka Puligandla, MS, Charlene Mantia, MD, Griffin M. Weber, MD PhD, Donna S Neuberg, ScD, Jeffrey I. Zwicker, MD

Blood (2019) 134 (Supplement_1): 2438.

https://doi.org/10.1182/blood-2019-126027

Published: 2019

Journal Articles

Near Universal Underestimation of the Risk of Recurrent Venous Thromboembolism (VTE)- an Institutional Survey of Thrombophilia

Tushar Pawar, MD MPH, Adam Cuker, MD, Ian Garrahy, DO, Anthony Donato, MD MHPE, Amber Stevenson, CMA, Daniel Forman, DO

Blood (2019) 134 (Supplement_1): 4978.

https://doi.org/10.1182/blood-2019-131480

Published: 2019

Journal Articles

Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: The Improve-VTE Study

Craig I. Coleman, PharmD, Alexander G. Turpie, MD, Thomas J. Bunz, PharmD, PhD, Jan Beyer-Westendorf, MD, William L Baker, PharmD

Blood (2018) 132 (Supplement 1): 1241.

https://doi.org/10.1182/blood-2018-99-114133

Published: 2018

Journal Articles

Bleeding and Thrombotic Outcomes Following Perioperative Interruption of Direct Oral Anticoagulants in Patients with Prior Venous Thromboembolic Disease

Joseph Shaw, MD BSc, Carine de Wit, BSc, Gregoire Le Gal, MD PhD, Marc Carrier, MD MSc, FRCPC

Blood (2016) 128 (22): 2614.

https://doi.org/10.1182/blood.V128.22.2614.2614

Published: 2016

Journal Articles

the Long-Term Recurrence Risk of Patients with Unprovoked Venous Thromboembolism: An Observational Cohort Study

Paul A Kyrle, MD, Michael Kammer, Lisbeth Eischer, Georg Heinze, Sabine Eichinger, MD

Blood (2016) 128 (22): 273.

https://doi.org/10.1182/blood.V128.22.273.273

Published: 2016

Journal Articles

A Platelet Count <50 x10 9 Was Not Associated with Increased Rates of Major Bleeding Among Anticoagulated Patients

Bethany T Samuelson, MD, Roland B. Walter, MD PhD, Terry Gernsheimer, MD, David A Garcia, MD

Blood (2016) 128 (22): 164.

https://doi.org/10.1182/blood.V128.22.164.164

Published: 2016

Journal Articles

Management of Anticoagulation in Patients with Hematologic Malignancy Undergoing Autologous Hematopoietic Cell Transplantation

Ang Li, MD, Chris Davis, Qian Wu, Madeline F Kesten, Ajay K Gopal, MD, David A Garcia, MD

Blood (2016) 128 (22): 1437.

https://doi.org/10.1182/blood.V128.22.1437.1437

Published: 2016

Journal Articles

A Pilot Study in Cancer Patients with Central Venous Catheter Associated Deep Vein Thrombosis in Upper Extremity Treated with Rivaroxaban (Catheter 2)

Gwynivere A Davies, MD FRCPC, Alejandro Lazo-Langner, MD MSc, FRCPC, Esteban Gandara, MD MSc, FRCPC, Vicky Tagalakis, MD MSc, Martha L Louzada, MD, Roweena Corpuz, RN, Michael J. Kovacs, MD FRCPC

Blood (2016) 128 (22): 878.

https://doi.org/10.1182/blood.V128.22.878.878

Published: 2016

Journal Articles

Direct Oral Anticoagulants in Patients with Cirrhosis Appear Safe and Effective

Paul R Kunk, MD, Hampton Collins, MD, Surabhi Palkimas, Pharm D., Nicolas M Intagliata, MD, Hillary S. Maitland, MD MS

Blood (2016) 128 (22): 3827.

https://doi.org/10.1182/blood.V128.22.3827.3827

Published: 2016

Journal Articles

The Risk of Major Bleeding with Low-Molecular-Weight-Heparins for Venous Thromboembolism in Dialysis Patients: The Q-VTE Study

Adi J. Klil-Drori, MD, Janie Coulombe, MSc, Sharon J. Nessim, MD MSc, Vicky Tagalakis, MD MSc

Blood (2016) 128 (22): 89.

https://doi.org/10.1182/blood.V128.22.89.89

Published: 2016

Journal Articles

Comparison of Rethrombosis-Free Survival in Children Versus Adults Suffering from Antithrombin-, Protein C- and Protein S-Deficiency: An Observational Multicenter Cohort Study

Verena Limperger, MD, Gili Kenet, MD, Christine Heller, MD, Ralf Knoefler, MD, Karin Kurnik, MD, Ulrich C Klostermeier, MD, Rolf Mesters, MD, Neil A Goldenberg, MD PhD, Guy Young, MD, Ulrike Nowak-Gottl, MD

Blood (2015) 126 (23): 2316.

https://doi.org/10.1182/blood.V126.23.2316.2316

Published: 2015

Journal Articles

Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism (VTE): A Retrospect of Real Life (EXTEND study - updated results)

Martha L Louzada, BSc, MD MSc, Fatimah Al-Ani, MD MRCP, Michael J. Kovacs, MD, Lenicio Siqueira, BSc, Alejandro Lazo-Langner, MD MSc

Blood (2015) 126 (23): 2320.

https://doi.org/10.1182/blood.V126.23.2320.2320

Published: 2015

Journal Articles

Non-Warfarin Oral Anticoagulants in Heparin-Induced Thrombocytopenia

Paul Kunk, MD, B. Gail Macik, MD, Jacqueline Brown, MD

Blood (2015) 126 (23): 3547.

https://doi.org/10.1182/blood.V126.23.3547.3547

Published: 2015

Journal Articles

Risk of Cancer after Long-Term Anticoagulation in Patients with Unprovoked Venous Thromboembolism

Sabine Eichinger, MD, Paul Alexander Kyrle, Michael Kammer, Lisbeth Eischer

Blood (2015) 126 (23): 3545.

https://doi.org/10.1182/blood.V126.23.3545.3545

Published: 2015

Journal Articles

Evaluation of Rivaroxaban and Dalteparin in Cancer Associated Thrombosis

Ateefa Chaudhury, MD, Asha Balakrishnan, MD, Christy Thai, PharmD, BCPS, Bjorn Holmstrom, MD, Michael V. Jaglal, MD

Blood (2015) 126 (23): 432.

https://doi.org/10.1182/blood.V126.23.432.432

Published: 2015

Journal Articles

Two Years Versus Six Months of Oral Anticoagulation after a First Episode of Unprovoked Pulmonary Embolism: The Padis PE Multicenter, Double-Blind, Randomized Trial

Blood (2014) 124 (21): LBA-3.

https://doi.org/10.1182/blood.V124.21.LBA-3.LBA-3

Published: 2014

Journal Articles

Outcomes of Central Venous Catheter Associated Upper Extremity Deep Vein Thrombosis in Cancer Patents

Aurelien Delluc, MDPhD, Gregoire Le Gal, MDPhD, Dimitrios Scarvelis, MD CM, FRCPC, Marc Carrier, MDMSc

Blood (2014) 124 (21): 4260.

https://doi.org/10.1182/blood.V124.21.4260.4260

Published: 2014

Journal Articles

Naturally Occurring Autoantibodies to Oxidation-Specific Epitopes in Patients with Venous Thromboembolism

Sabine Eichinger, MD, Paul A Kyrle, MD, Michael Kammer, MSc, Lisbeth Eischer, MD, Christoph Binder, MD

Blood (2014) 124 (21): 2861.

https://doi.org/10.1182/blood.V124.21.2861.2861

Published: 2014

Journal Articles

Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism: A Retrospect of Real Life (EXTEND Study)

Martha L Louzada, BSc, MD MSc, Michael J. Kovacs, MD FRCPC, Fatimah Al-ani, MD, Lenicio Siqueira, Alejandro Lazo-Langner, MD MSc

Blood (2014) 124 (21): 4245.

https://doi.org/10.1182/blood.V124.21.4245.4245

Published: 2014

NARROW

Clinical Outcomes of Cancer-Associated Thrombosis Beyond 6 Months of Anticoagulation

Recurrent Intracranial Hemorrhage and Venous Thromboembolism Following Initial Intracranial Hemorrhage in Patients with Brain Tumors on Anticoagulation

Near Universal Underestimation of the Risk of Recurrent Venous Thromboembolism (VTE)- an Institutional Survey of Thrombophilia

Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: The Improve-VTE Study

Bleeding and Thrombotic Outcomes Following Perioperative Interruption of Direct Oral Anticoagulants in Patients with Prior Venous Thromboembolic Disease

the Long-Term Recurrence Risk of Patients with Unprovoked Venous Thromboembolism: An Observational Cohort Study

A Platelet Count <50 x10 9 Was Not Associated with Increased Rates of Major Bleeding Among Anticoagulated Patients

Management of Anticoagulation in Patients with Hematologic Malignancy Undergoing Autologous Hematopoietic Cell Transplantation

A Pilot Study in Cancer Patients with Central Venous Catheter Associated Deep Vein Thrombosis in Upper Extremity Treated with Rivaroxaban (Catheter 2)

Direct Oral Anticoagulants in Patients with Cirrhosis Appear Safe and Effective

The Risk of Major Bleeding with Low-Molecular-Weight-Heparins for Venous Thromboembolism in Dialysis Patients: The Q-VTE Study

Comparison of Rethrombosis-Free Survival in Children Versus Adults Suffering from Antithrombin-, Protein C- and Protein S-Deficiency: An Observational Multicenter Cohort Study

Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism (VTE): A Retrospect of Real Life (EXTEND study - updated results)

Non-Warfarin Oral Anticoagulants in Heparin-Induced Thrombocytopenia

Risk of Cancer after Long-Term Anticoagulation in Patients with Unprovoked Venous Thromboembolism

Evaluation of Rivaroxaban and Dalteparin in Cancer Associated Thrombosis

Two Years Versus Six Months of Oral Anticoagulation after a First Episode of Unprovoked Pulmonary Embolism: The Padis PE Multicenter, Double-Blind, Randomized Trial

Outcomes of Central Venous Catheter Associated Upper Extremity Deep Vein Thrombosis in Cancer Patents

Naturally Occurring Autoantibodies to Oxidation-Specific Epitopes in Patients with Venous Thromboembolism

Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism: A Retrospect of Real Life (EXTEND Study)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only